Share of the population living with HIV receiving antiretroviral therapy in Latvia
Latvia: Share of the population living with HIV receiving antiretroviral therapy was 52.4% in 2024. ◆ Volatile
Share of the population living with HIV receiving antiretroviral therapy in Latvia, 1990–2024
Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.
Analysis
The most recent figure for share of the population living with hiv receiving antiretroviral therapy in Latvia is 52.4%, measured in 2024. That is the highest value across all 35 years on record.
The figure is up 1.9% on the previous year and up 275.6% over ten years.
Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Latvia peaked at 52.4% in 2024 and was at its lowest, 0.0%, in 1990.
Latvia ranks 122nd of 149 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | 10 |
| 2000s | 3.2% | 0.9% | 7.7% | 10 |
| 2010s | 22.0% | 8.8% | 46.1% | 10 |
| 2020s | 50.0% | 47.3% | 52.4% | 5 |
Countries ranked near Latvia
More reference data data for Latvia
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.128 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.0503 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 0.4657 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.0673 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 0.4657 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.4291 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.2986 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 0.2679 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 2.27 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.3666 (2050)
Frequently asked questions
- What is share of the population living with hiv receiving antiretroviral therapy in Latvia?
- Share of the population living with hiv receiving antiretroviral therapy in Latvia was 52.4% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
- What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Latvia?
- The highest recorded value was 52.4% in 2024.
- What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Latvia?
- The lowest recorded value was 0.0% in 1990.
- How does Latvia rank for share of the population living with hiv receiving antiretroviral therapy?
- Latvia ranks 122nd out of 149 countries with data for 2024.
- Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Latvia?
- Over the last ten years it is up 275.6%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.